ORGO Q4 2017 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena

ORGOOrganogenesis Holdings Inc.

$338M

Q4 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$7M+10683.8% YoY

Gross Profit

$5M80.3% margin

Operating Income

-$1M-19.7% margin

Net Income

-$498,107-7.6% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$91,842

Free Cash Flow

-$91,842

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$313M

Total Liabilities

$15M

Stockholders' Equity

$298M

Cash & Equivalents

$125,886

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$61,084	+10683.8%
Gross Profit	$5M	-$117,072	+4617.7%
Operating Income	-$1M	$178,156	-828.7%
Net Income	-$498,107	-$178,156	-179.6%